Amyris Revenue and Competitors

Location

$1.8B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Amyris's estimated annual revenue is currently $356.8M per year.(i)
  • Amyris received $30.0M in venture funding in October 2016.
  • Amyris's estimated revenue per employee is $247,420
  • Amyris's total funding is $1.8B.
  • Amyris's current valuation is $1.5B. (January 2022)

Employee Data

  • Amyris has 1442 Employees.(i)
  • Amyris grew their employee count by 25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M130-56%$974.1M$562.2M
#2
$300.1M85437%N/AN/A
Add Company

Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Household & Personal Products,Personal Products,Pharmaceuticals,Wind Power

$1.8B

Total Funding

1442

Number of Employees

$356.8M

Revenue (est)

25%

Employee Growth %

$1.5B

Valuation

N/A

Accelerator

Amyris News

2022-04-20 - Brokerages Anticipate Amyris, Inc. (NASDAQ:AMRS) to Post ...

On average, analysts expect that Amyris will report full year earnings of ($0.73) per share for the current year, with EPS estimates ranging...

2022-04-17 - Amyris starts commissioning of new fermentation capacity in ...

The greenfield site at Barra Bonita is a strategic investment with which Amyris leads the biotechnology sector with manufacturing at industrial...

2022-04-13 - AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT

EMERYVILLE, Calif., April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the...

2021-09-07 - Amyris Closes Acquisition Of Beauty Labs Combining Synthetic Biology Leadership With Digital Innovation

EMERYVILLE, Calif., Sept. 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, on August 31, it closed the a ...

2021-08-24 - Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower

EMERYVILLE, Calif., Aug. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$600.9M20606%$1000M
#2
$300M437010%N/A

Amyris Funding

DateAmountRoundLead InvestorsReference
2006-10-13$20.0MAKhosla VenturesArticle
2007-09-20$70.0MBDuff Ackerman and Goodrich VenArticle
2008-08-15$21.0MUndisclosedMultipleArticle
2009-08-24$24.8MThirdArticle
2009-10-02$41.8MCArticle
2010-04-01$47.8MUndisclosedTemasek HoldingsArticle
2013-08-09$60.0MUndisclosedTemasek Life Science VenturesArticle
2015-02-25$50.0MUndisclosedNomis Bay LtdArticle
2015-10-15$50.0MUndisclosedArticle
2016-10-07$30.0MUndisclosedArticle